ArticleAsian Pacific journal of cancer prevention : APJCP2024

Evaluation of the Expression EGFR, HER2/NEU and the End Effector ERK of the RAS/RAF/MAP Kinase Pathway in Prostatic Adenocarcinoma for a Possible Role as New Target Therapy.

Asem Shalaby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.